Eisai CoESAIY +0.34%66 FCF Yield % is 2.00 as of Jun. 25, 2026, which is 62% below its 10-year median of 5.20. GuruFocus rates ESAIY with a GF Score™ of 66/100 and a GF Value™ of $8.73 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Eisai Co ranks better than 58.11% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Eisai Co FCF Yield % Related Terms
Eisai Co FCF Yield % Historical Data
* Premium members only.
The historical data trend for Eisai Co's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eisai Co FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Eisai Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Eisai Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eisai Co (ESAIY) has a FCF Yield % of 2.00 as of Jun. 25, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Eisai Co and its competitors. This is 62% below median its historical median of 5.20. According to the industry distribution chart, Eisai Co ranks #421 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 41.9%.
Is Eisai Co's FCF Yield % too high?
Eisai Co's current FCF Yield % of 2.00 is 62% below median its 10-year median of 5.20. The Drug Manufacturers industry median FCF Yield % is 0.69. Eisai Co's value of 2.00 is 189.9% above this industry median. Based on the distribution chart, Eisai Co ranks #421 out of 1005 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Eisai Co has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eisai Co's FCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Eisai Co ranks #421 out of 1005 companies for FCF Yield %. This puts Eisai Co in the upper half of its industry. The industry median FCF Yield % is 0.69. Eisai Co's value of 2.00 is 189.9% above this benchmark. While the company's 10-year median is 5.20 vs. the industry median of 0.69, Eisai Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.69, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eisai Co's current FCF Yield % of 2.00 is 189.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Eisai Co and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eisai Co's current FCF Yield % is 2.00, which is 62% below median its own 10-year median of 5.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eisai Co stock overvalued right now?
Based on GuruFocus' analysis, Eisai Co (ESAIY) is currently considered Significantly Undervalued. The stock's GF Value™ is $8.73, compared to a current price of $5.98 — trading 31.5% below its estimated fair value. The current FCF Yield % is 2.00, which is 62% below median its 10-year median of 5.20 and 189.9% above the Drug Manufacturers industry median of 0.69. Eisai Co's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Eisai Co (ESAIY), the current FCF Yield % is 2.00 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eisai Co (ESAIY) Overvalued in 2026?
Based on GuruFocus' analysis, Eisai Co stock appears to be undervalued.
The current stock price of $5.98 is trading 31.5% below its estimated GF Value™ of $8.73.
GuruFocus considers Eisai Co to be Significantly Undervalued.
Key valuation signals for ESAIY:
FCF Yield %: 2.00 (62% below median its 10-year median of 5.20)
GF Value™: $8.73 vs. price of $5.98 (31.5% below fair value)
Industry Position: 189.9% above the Drug Manufacturers median (#421 of 1005)
No single metric tells the full story. See the ESAIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
66GF Score
Get the complete analysis for ESAIY
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ESAIY has been successfully added to your 
